Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study
Conditions: Type1 Diabetes Sponsors: Jaeb Center for Health Research; Juvenile Diabetes Research Foundation; University of Minnesota Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Type 1 | Endocrinology | Research | Study | University of Minnesota | Verapamil